Profile picture

Professor Ileana Pina

Thomas Jefferson University, Philadelphia (United States of America)
Membership: ESC Professional Member HFA Member
Follow
Biography
Write your professional biography here ... I am a heart failure/transplant/VAD cardiologist and quality chair at Thomas Jefferson University. I am a clinical trialist and research interests in transitions of care and the use of biomarkers in the clinical setting. Also interested in the exercise physiology of heart failure and inclusion of underrepresented minorities in clinical trials. I speak Spanish as well. Professor of Medicine Thomas Jefferson University, Philadelphia Chair of Quality for the CV Line Clinical Professor Central Michigan University Senior Staff Fellow FDA, CDRH, Medical Officer
Logo ESC

Contributor content

Cardiac and extracardiac comorbidities in heart failure
Session
Cardiac and extracardiac comorbidities in heart failure
1 September 2024
Cardiac amyloidosis, sarcoidosis, and inflammation
Session
Cardiac amyloidosis, sarcoidosis, and inflammation
31 August 2024
Multiprofessional management: achieving the best quality of care for heart failure
Session
Multiprofessional management: achieving the best quality of care for heart failure
28 August 2023
Practical guidance to implement heart failure treatment with SGLT2 inhibitors in the hospital setting
Session
Practical guidance to implement heart failure treatment with SGLT2 inhibitors in the hospital setting
26 August 2023
Hyperkalemia - Is it still a challenge in 2023?
Session
Hyperkalemia - Is it still a challenge in 2023?
22 May 2023
Heart failure - clinical cases multi-topics 3
Session
Heart failure - clinical cases multi-topics 3
21 May 2023
The ESC and BigData@Heart CODE-EHR framework for using routine healthcare data in clinical research
Session
The ESC and BigData@Heart CODE-EHR framework for using routine healthcare data in clinical research
29 August 2022
Chronic heart failure - Pathophysiology and mechanisms
Session
Chronic heart failure - Pathophysiology and mechanisms
28 August 2022
HFpEF and HFmrEF: what’s new in treatment?
Session
HFpEF and HFmrEF: what’s new in treatment?
27 August 2022
Time to act: how can we improve outcomes for patients following a worsening heart failure event?
Session
Time to act: how can we improve outcomes for patients following a worsening heart failure event?
27 August 2022

ESC 365 is supported by